These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15577127)

  • 1. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
    Azuma K; Inoue S
    Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogen receptor subtypes and the regulatory effect of receptor ligand binding on gene transcription].
    An SJ; Zhang YX
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):309-12. PubMed ID: 12650065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedicine. Defining the "S" in SERMs.
    Katzenellenbogen BS; Katzenellenbogen JA
    Science; 2002 Mar; 295(5564):2380-1. PubMed ID: 11923515
    [No Abstract]   [Full Text] [Related]  

  • 8. Signaling by estrogens.
    Cheskis BJ; Greger JG; Nagpal S; Freedman LP
    J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of tissue-specific actions of SERM].
    Kato S
    Clin Calcium; 2006 Sep; 16(9):1469-74. PubMed ID: 16951470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective estrogen receptor modulators (SERMs)].
    Matsumoto T
    Clin Calcium; 2006 Sep; 16(9):1520-25. PubMed ID: 16951478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease.
    Bolego C; Vegeto E; Pinna C; Maggi A; Cignarella A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2192-9. PubMed ID: 16917104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific modulators of estrogen action].
    Guiochon-Mantel A
    Gynecol Obstet Fertil; 2000 Jun; 28(6):429-34. PubMed ID: 10935307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters.
    Mukherjee S; Saha A; Roy K
    Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
    Cox DA; Helvering LM
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):53-9. PubMed ID: 16426741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of tissue-specific actions of sex steroid hormones and SERM for bone remodeling].
    Kato S
    Clin Calcium; 2005 May; 15(5):825-30. PubMed ID: 15876746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S
    Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.